The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
We could well have had the shake out and these could start moving back up. I'm still very excited about the comment below which could turn this around overnight. Bods are heavily invested which means they feel our pain and will do whatever they can to relieve that.
"Confidential discussions commenced with third parties regarding monetizing OBD's two most advanced"
Let's be honest, the reason they've pulled out is that the next share placement will decimat existing shareholder value. These companies work on probability, and what is a definite is that Evgen will need more funds before year end. Admittedly Stalicla could pay out but the odds of that happening are way to high.
Please stop saying that the seller has finally finished, I've been hearing the same line for the last 2 years and each time a new seller joins.
The CEO could be everyone's best friend again if he does succeed in monotising the products. That's what I'm holding out for.
I've had this on my radar for a while, didn't think we'd be back down here but there is a gap that needs filling at around 10.9p
I didn't realise how high the salaries were and more importantly how much the bods pay themselves. Surely it would have been more worthwhile hiring a bigger sales team rather than depending on one superstar who just happened to be off during a crucial time. Seems we have way to many expensive head chefs and not enough cooks.
Maybe down but at least they have a couple of live products. It was always about finding a buyer, OBD are not set up for mass marketing and sales.
They confirmed on Wednesday that there are confidential discussions with 3rd parties.
Oh and the bods are heavily invested.
Watch this space
I do think we have all been a little harsh with this company over the last few days.
Let's not forget they have a great product, and the bods are heavily invested so they definitely have shareholder value at heart.
I would seriously consider topping up here if a new placement wasn't on the horizon, I'm therefore going to keep my powder dry and subscribe. Don't let all these negative comments panic you out, the bods have given us all a great opportunity to buy in at a super low level.
One hour and 4 minutes in he seems to make a basic maths error. If he produces it for $150 and sells it for $1000 that is not a 90% margin.
Hopefully he is just a figure head and won't be responsible for the overall sales negotiations, his lack of basic maths will result in giving the company away for nothing
I'm sticking it out, these could turn around overnight with a bid. Too many on here have over speculated and are now panicking out hence the massive drop. At the end of the day they have a proven product that's literally worth billions.
That's 0.0085p
I'd wait, I can see these as low as 0.85p
Maybe it's just me, but I wasn't never of the opinion that OBD would be able to scale this up and become a mass producer, they are not set up for that. My hope was that a third party would come in and deal with all the mass marketing ect.
I think it's great news that they announced
Surly this statement is what will push these higher
"Confidential discussions commenced with third parties regarding monetizing OBD's two most advanced pipeline assets"
They are in talks with more than one interested party It's exactly what we need but clearly the market is focusing on in my eyes irrelevant sales figures. Eagerly awaiting news regarding a bid or possibly 2
Surly this statement is what will push these higher
Confidential discussions commenced with third parties regarding monetizing OBD's two most advanced pipeline assets: EpiSwitch® NST (No Stool Test) for colorectal/bowel cancer and EpiSwitch® SCB (Specific for Canine Blood) blood test for detection of multiple types of canine cancer
Very strange RNS, is Huw trying to give the impression that now Stalicla have raised all this money, Evgen could be inline for a payout ???
Is this what him and Toni were referring to when they said that they were working on adding to shareholder value, creating false impression that will lead to a speculative frenzy so as to suck in more unsuspecting punters.
The whole communication is poorly written and leaves more questions than answers. One certainty is that it adds more weight to the argument that he is out of his depth and a complete amateur.
CJ39 - I could be completely wrong but I don't think they were ever at £1.50, I seem to recall them originally being issued at around 35p.
Funny how Proinvester has gone away, might have decided that his ramping wasn't working and has sold out.
I do think existing shareholders should start to consider ousting Huw during the next AGM. He has proved to be completely out of his depth, blatantly lying and ramping up the share price just before a share placement announcement.
Funny how some on here view Toni as some kind of saviour, I personally think he is just another drain on a shrinking reserve. The company has way to many directors who all hold second or third jobs being paid a full time salary it's scandalous.
Why is Huw still at the helm, having presided over a 90% share decline he is somewhat fortunate to still have a job, in any other job with proper checks and balances he would have been long gone.